Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. [electronic resource]
Producer: 20101014Description: 747-61 p. digitalISSN:- 1476-5381
- Animals
- Butadienes -- pharmacology
- Cell Culture Techniques
- Cell Death -- drug effects
- Cell Line, Transformed
- Cerebellum -- metabolism
- Cyclic AMP -- metabolism
- Dronabinol -- analogs & derivatives
- GTP-Binding Protein alpha Subunits -- metabolism
- Humans
- Huntingtin Protein
- Huntington Disease -- prevention & control
- Mice
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Nerve Tissue Proteins -- metabolism
- Neuroprotective Agents -- pharmacology
- Nitriles -- pharmacology
- Nuclear Proteins -- metabolism
- PC12 Cells
- Pertussis Toxin -- pharmacology
- Piperidines -- pharmacology
- Pyrazoles -- pharmacology
- Rats
- Receptor, Cannabinoid, CB1 -- agonists
- Receptors, Dopamine -- drug effects
- Rimonabant
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.